During the past decade, Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Center" #1 collaborator was "Astellas Pharma Europe B.V." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Research Center" are "CKD Anemia in Stable Dialysis Patients" (1 trials) and "Chronic Heart Failure" (1 trials). Many other conditions were trialed in "Research Center" in a lesser frequency.

Most popular intervention types in "Research Center" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5% dextrose in water" (1 trials), "Epoetin Alfa" (1 trials), "Roxadustat" (1 trials) and "Vepoloxamer" (1 trials). Other intervention names were less common.

The vast majority of trials in "Research Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".